• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Health Tech VC Firm Nina Capital Launches $47.4M Second Fund, Closes 5 Investments

by Fred Pennic 07/29/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Health Tech VC Firm Nina Capital Launches $47.4M Second Fund, Closes 5 Investments

What You Should Know:

– Nina Capital, a health tech venture capital (VC) firm, announced its last five investments of its first fund and the launch of its second fund, Nina Capital Fund II FCRE, with an investment goal of EUR 40 ($47.4M).

– Nina Capital was founded in 2019 with its inaugural fund, Nina Capital Fund I FCRE, which reached its maximum size of EUR 18 million (USD 21.3 million). In less than two years, Nina Capital has created an international portfolio of 23 companies in the U.S., Canada, and 11 European countries. To date, the firm has analyzed more than 2,000 health tech companies in pre-seed, seed, and Series A stages.


Recent Investments

Following are the five most recent and last pre-seed and seed companies whose funding agreements closed in the first fund: 

– The Lowdown (United Kingdom). A pre-seed company, The Lowdown is an online platform with multiple information layers and services to facilitate access to the right reproductive contraception method, including a telemedicine service portal and a prescription process integrated with a pharmacy.

– Promptly Health (Portugal). Promptly Health is a seed-stage company that aggregates clinical and claim data and complements it with real-world evidence and analysis of outcomes to enable the transition to value-based payment contracts, all with a patient-centric vision.    

– Zetta Genomics (United Kingdom & Spain). Zetta Genomics has created a flexible, scalable and secure platform that enables ease of accessibility and integration of genomics data, even in clinical settings, in the face of continuous advances in genomic sequencing techniques.

– Lena (United States). Lena, a seed-stage company born out of the Texas Medical Center, has developed a way to digitize health assistants for senior care navigation by leveraging artificial intelligence (AI) and Natural Language Processing (NLP) in order to make personalized care navigation scalable.

– Undisclosed (Europe). This undisclosed company is seed-stage and accelerates the clinical diagnostic pathway for atrial fibrillation by providing convenient, automated electrocardiogram interpretation to healthcare professionals.


Nina Capital Fund II Overview

Nina Capital Fund II FCRE will maintain the firm’s focus of investing in health technology companies in the pre-seed and seed investment stages with the capacity to reach Series A.  As its predecessor fund, Nina Capital Fund II FCRE will target need-driven businesses that deliver innovative and highly scalable solutions built to address the pain points of providers and other healthcare organizations. The value-based process of new venture creation known as Biodesign, born at Stanford University, remains core to the firm’s investment approach.

The firm expects to hold a first closing for its newly registered fund in the fall. “We have the excellent support of our existing investor base, plus new investors who have taken notice of our ability to seek, find, and serve the right design-minded and cross-disciplinary founders,” said Dr. Zanchi. Nina Capital Fund II FCRE is expanding its investor base with funds from other investment firms, international family offices, as well as individual investors with finance, management, and healthcare backgrounds, she added.

“Nina Capital continues to grow by both the size of our company portfolio and the number of investor partners due to our clearly defined positioning in a fast-growing, ever-changing market,” said Dr. Zanchi. “Most importantly, we have assembled the right team and right competencies to invest with strong conviction based on deep sector expertise and startup business development strategies. Our second fund will continue to demonstrate the strength of our team as well as the bright future of the entrepreneurs we fund.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |